Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
A completed clinical trial comparing three in vivo microscopic imaging techniques for diagnosing pigmented skin tumors conducted by Centre H…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: RATIO: Rational Approach To Immuno-Oncology [NA]
A clinical trial update for the RATIO study on immuno-oncology in metastatic melanoma indicates the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients [NA]
This clinical trial update reports the completion of a study evaluating sphingolipids as predictive biomarkers for response to immune checkp…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Sequential Combo Immuno and Target Therapy (SECOMBIT) Study [Phase 2]
The SECOMBIT Phase 2 trial in metastatic melanoma has completed, evaluating sequential immunotherapy and targeted therapy.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention [Phase 1]
Phase 1 trial evaluating a gut microbiome intervention in patients with metastatic melanoma to explore effects on checkpoint-related respons…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Real-world data on the use, safety, and effectiveness of nivolumab in melanoma and lung cancer from routine oncology practice.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety and efficacy of encorafenib with or without binimetinib in combination with nivolumab and low-dose ipili…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating stereotactic radiation therapy with ipilimumab for metastatic melanoma has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors [Phase 1]
Phase I trial update of T cells engineered to express an anti-GD2 chimeric antigen receptor in children and young adults with GD2-positive s…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: MB-CART20.1 Melanoma [EARLY_Phase 1]
Miltenyi Biomedicine's MB-CART20.1 trial for melanoma (early-phase 1) has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Etude rétrospective Monocentrique MATRIX
A retrospective monocentric study named MATRIX focusing on melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors [NA]
A completed clinical trial evaluated a wearable device designed to improve sun-protection behaviors in melanoma survivors, and results have …
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 [Phase 1]
A first-in-human Phase 1 trial of BMC128 in combination therapy evaluating a single dose level, across multiple cancers; status is active bu…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab
Retrospective analysis of melanoma patients treated with pembrolizumab evaluating response markers and adverse events to understand associat…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Nivo/Ipi Combination Therapy in Symptomatic Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating the nivolumab and ipilimumab combination in symptomatic melanoma with brain metastases has been terminated…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Elevated LDH Serum Levels and FDG-PET in Metastatic Melanoma Patients
This completed clinical trial update investigates elevated LDH serum levels and FDG-PET imaging findings in patients with metastatic melanom…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Identification of Predictive Parameters for Colitis in Melanoma Patients Treated With Immunotherapy.
Clinical trial update reporting on predictive parameters for colitis in melanoma patients treated with immunotherapy.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: [18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis [NA]
The trial evaluating the radiolabeled imaging agent [18F]Dabrafenib for detecting melanoma brain metastases has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Quality of Life and Physical Fitness After Immune Checkpoint Inhibitors
A completed clinical trial evaluates quality of life and physical fitness in patients treated with immune checkpoint inhibitors for melanoma…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: PD-L1 PET Imaging in Melanoma Patients [NA]
A completed clinical trial assessing PD-L1 PET imaging in patients with melanoma, sponsored by University Medical Center Groningen.
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: IL2 Imaging in Metastatic Melanoma [NA]
A clinical trial studying IL-2 imaging for metastatic melanoma conducted by University Medical Center Groningen has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: A Study of a Monoclonal Antibody, KW-2871, in Patients With Advanced Melanoma [Phase 1, Phase 2]
A phase 1/2 study evaluating the monoclonal antibody KW-2871 in patients with Stage IV melanoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Pembrolizumab-PET Imaging [NA]
This clinical trial update notes the completion of a pembrolizumab-PET imaging study involving melanoma and non-small cell lung cancer.